Crossmark

Prospective randomized, placebo-controlled study: role of branched-chain amino acids infusion as adjunct therapy post-liver surgery for patients in the intensive care unit

Crossref DOI link: https://doi.org/10.1186/s12876-025-03696-3

Published Online: 2025-06-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mahmoud, Eman Ibrahim El-Desoki

Awdallah, Faten Farid
License Information

Text and Data Mining valid from 2025-06-19

Version of Record valid from 2025-06-19
More Information

Article History

Received: 4 January 2024

Accepted: 13 February 2025

First Online: 19 June 2025

Declarations

:

: The protocol was approved by the institutional review board of the national hepatology and tropical medicine research institute (NHTMRI), Cairo, Egypt. All study procedures were performed in accordance with good clinical practice and the declaration of Helsinki. Written informed consent was obtained from each patient or a legally authorized representative prior to enrollment in the study. The patients' information is kept confidential and not to be viewed except by those who are conducting the research. All patients have the right to refuse to continue the study at any time or not to be included from the start.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below